Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1332 of 6351
-
Hidden clots in heart failure? new study tests routine screening
Diagnosis Recruiting nowThis study focuses on two serious and common medical conditions: heart failure and pulmonary embolism (a blood clot in the lungs). Heart failure happens when the heart cannot pump blood effectively, and it is one of the main reasons older adults are admitted to the hospital. Pulm…
Sponsor: University Hospital, Angers • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Sound waves against ALS: can opening the Brain's barrier slow the disease?
Disease control Recruiting nowThis is proof-of-concept, single-arm, single-center study to assess the safety and explore the efficacy of repeated US transient disruptions of the blood-brain barrier (BBB) in Amyotrophic Lateral Sclerosis (ALS). Phase 1: The primary objective is to assess the safety of ultras…
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Cottonseed compound plus immunotherapy takes on tough colorectal cancer
Disease control Not yet recruitingThis is a single-center, open-label, single-arm, exploratory phase II clinical trial designed to evaluate the preliminary efficacy and safety of sintilimab in combination with oral gossypol acetate in patients with advanced pMMR/MSS colorectal cancer after failure of at least two…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug XYA02 takes on tough cancers in first human trial
Disease control Not yet recruitingThis study will evaluate the safety, tolerability, and efficacy of XYA02 in participants with advanced solid tumors.
Phase 1/2 • Sponsor: XYone Therapeutics, Inc • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Swallowable balloon offers Non-Surgical weight loss hope
Disease control Not yet recruitingThe primary purpose of this study is to confirm the safety profile results for the Allurion Gastric Balloon System (AGBS).
Sponsor: Allurion Technologies • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a smartphone app tame OCD? scientists investigate digital mindfulness
Disease control Recruiting nowThis randomized controlled trial aims to evaluate the effects of digital mindfulness-based therapy in people with obsessive-compulsive disorder and to explore its possible psychological and neurophysiological mechanisms. A total of 150 participants with a primary diagnosis of ob…
Sponsor: Central South University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Rhythmic sound may retrain the brain to walk better after TBI
Symptom relief Not yet recruitingThe goal of this study is to learn whether a home-based rhythmic auditory stimulation (RAS) program using the MR-001 device can help improve walking, balance, and other health outcomes in adults with moderate to severe traumatic brain injury (TBI). The study will also look at how…
Sponsor: Craig Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Real-World study tests Once-Daily pill for ulcerative colitis in chinese adults
Disease control Not yet recruitingUlcerative colitis (UC) is a chronic inflammatory bowel disease that causes symptoms such as bloody diarrhea, abdominal pain, and frequent bowel movements. It can significantly affect patients' quality of life. Etrasimod is an oral medication taken once daily that has been shown …
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Hidden clues in ovarian tissue: a study hunts for early cancer signals in BRCA carriers
Knowledge-focused Not yet recruitingHigh-grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy and is typically diagnosed at an advanced stage, limiting opportunities for early detection and intervention. Women carrying germline pathogenic variants in BRCA1 or BRCA2 have a substantially incr…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Could fewer antibiotics be better for older women with urinary symptoms?
Diagnosis Not yet recruitingThis project aims to improve the diagnosis and management of urinary tract symptoms in older women by comparing three common treatment strategies-empiric antibiotics, urinalysis-guided therapy, and culture-directed care-in a randomized trial. By integrating patient-reported outco…
Phase 3 • Sponsor: Megan Bradley • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Eyes on the brain: could a quick eye scan detect concussion?
Diagnosis Recruiting nowThe early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to …
Sponsor: Rebiscan, Inc. • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Could spinal anesthesia make hysterectomy recovery easier?
Symptom relief Not yet recruitingVaginal natural orifice transluminal endoscopic surgery is recognized as a significant advancement in women's health, representing an extension of minimally invasive surgery. Research and clinical experience with this technique are ongoing, contributing to its increasing adoption…
Sponsor: Cukurova University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
A daily capsule that could turn back the clock on facial aging?
Symptom relief OngoingThe present clinical study has been designed to evaluate the efficacy and safety of Dermial® at a daily dose of 60 mg on skin brightness, hydration, luminosity and other signs of facial skin aging in healthy women aged 35 to 65 years presenting physiological age-related skin agin…
Sponsor: Bioiberica • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Shorter radiation after thymic tumor surgery may cut side effects
Disease control Recruiting nowThis is a prospective, open-label, single-arm Phase II study designed to evaluate the safety of postoperative hypofractionated radiotherapy in patients with Stage II/III thymic epithelial tumors after complete resection. After a screening period of up to 28 days, eligible patient…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New combo pill attack aims to control blood cancers
Disease control Recruiting nowBTK inhibitors and BCL-2 inhibitors have demonstrated significant clinical activity in mature B-cell malignancies, and combination therapy may provide improved clinical benefit. This is a multi-center, open-label, single-arm Phase Ib/II clinical study. The purpose of this clinica…
Phase 1/2 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could One-Time TB pill delivery stop the spread?
Prevention Recruiting nowThe goal of this clinical trial is to learn if differentiated service delivery (DSD) of TB preventive therapy (TPT) improves uptake and completion of TPT in two populations: household contacts (HHC) of index TB patients and people living with HIV (PWH). The main questions it aims…
Sponsor: University of Washington • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
A supplement aims to fight fatigue in women — a rigorous trial puts it to the test
Symptom relief Not yet recruitingRadicle Women's Health DNSTM: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related women's health outcomes
Sponsor: Radicle Science • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Nanoparticle cleaning may calm pain after failed root canals in diabetic patients
Symptom relief Recruiting nowThe ultimate biological aim of endodontic therapy is to either prevent or heal apical periodontitis. Root canal treatment can fail for various reasons, such as persistent infection, missing canals, ledges, canal transportation, instrument separation, and perforation. Post-treatm…
Sponsor: Minia University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
AI vs. human eye: a new test for measuring bedsores
Diagnosis OngoingThe goal of this clinical trial is to learn if AI grid image recognition can measure pressure ulcer wound area accurately and efficiently in adult patients with pressure ulcers. The main questions it aims to answer are: * Can AI grid image recognition shorten the single measurem…
Sponsor: Affiliated Hospital of Nantong University • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
New mRNA treatment targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe goal of this phase 1 clinical trial is to evaluate the safety, tolerability, and preliminary antitumor activity of a peptide-delivered IL-22BP biotherapy in patients with advanced solid tumors. The main questions it aims to answer are: Is the IL-22BP formulation safe and tol…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC